CIBC World Market
BIO icon

CIBC World Market’s Bio-Rad Laboratories Class A BIO Stock Holding History

CIBC World Market’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-735
Closed -$245K – 1130
2019
Q3 		$245K Sell
735
-584
-44% -$191K ﹤0.01% 959
2019
Q2 		$412K Sell
1,319
-1,611
-55% -$482K ﹤0.01% 860
2019
Q1 		$896K Buy
2,930
+477
+19% +$129K ﹤0.01% 695
2018
Q4 		$570K Buy
+2,453
New +$658K ﹤0.01% 747

Other funds holding BIO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ACM
Atlanta Capital Management Atlanta, Georgia $22.5B AUM 9.67% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $23.8B AUM 49.45% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

CIBC World Market's BIO Position: Q4 2019 in Review

CIBC World Market sold out of Bio-Rad Laboratories Class A (BIO) in Q4 2019, closing a stake of 735 shares — an estimated $245K sold.

CIBC World Market first reported a position in BIO in Q4 2018 and held it in 4 quarters. The position peaked at $896K in Q1 2019. 386 funds tracked by Wall St. Rank hold BIO as of Q4 2019.

  • CIBC World Market reported no remaining Bio-Rad Laboratories Class A position as of Q4 2019 after selling out during the quarter.
  • CIBC World Market sold 735 Bio-Rad Laboratories Class A shares in Q4 2019, an estimated $245K.
  • CIBC World Market first reported a position in Bio-Rad Laboratories Class A in Q4 2018 and held it in 4 quarters.
  • CIBC World Market's Bio-Rad Laboratories Class A position peaked at $896K in Q1 2019.
  • 386 funds tracked by Wall St. Rank held Bio-Rad Laboratories Class A as of Q4 2019.

Based on CIBC World Market's 13F filing for Q4 2019, filed 13 Feb 2020.